
Bacterin (NYSE Amex: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin’s proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.
For more information, please visit http://www.bacterin.com.
Up to 90% verified emails and mobile numbers, refreshed weekly.
Bacterin International, Inc. operates in the Biotechnology Research industry and is headquartered in United States.
Bacterin International, Inc. has approximately 51-200 employees employees.
Bacterin International, Inc. is based in Belgrade, MT, United States.
Yes. Bacterin International, Inc. is a publicly traded company.
You can reach Bacterin International, Inc.’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.
Our team will be in touch soon. If you have any questions, please email us at info@scalelist.com
Just a few more details..
Our team will be in touch soon. If you have any questions, please email us at arnaud@scalelist.com